Insider · SEC Form 4 filer

667, L.P.

Past buys: 2 of 3 beat

Companies

Where they file as an insider

Kodiak Sciences (KOD) Director, 10% owner Latest filing Sep 29, 2026
Incyte (INCY) Director, 10% owner Latest filing Mar 31, 2026
IGM Biosciences (IGMS) Director, 10% owner Latest filing Jun 30, 2025
Immunocore (IMCR) Director Latest filing Mar 17, 2025
Kymera Therapeutics (KYMR) Director Latest filing Aug 20, 2024
Bicycle Therapeutics (BCYC) Director, 10% owner Latest filing Jun 17, 2024
vTv Therapeutics (VTVT) Director Latest filing Mar 5, 2024
Seagen (SGEN) Director Latest filing Dec 14, 2023

And 1 more company with older filings.

Track record

Did their buys beat the typical stock?

Open-market buys57
Quarters checked 6 months later3
Beat the typical stock 2 of 3
Quarters too new to check1

2 of 3 checked quarters beat the typical stock. A past record is data, not a forecast.

Kodiak Sciences (KOD) Bought Sep 28–29, 2026 · $63.4M · 715,592 shares Too new Too new. Its 6-month check uses prices as of Mar 31, 2027.
Immunocore (IMCR) Bought Mar 17, 2025 · $24M · 807,338 shares Beat typical Mar 31, 2025 $29.67 → Sep 30, 2025 $36.33 · +22.4% (typical stock +7.3%)
Kymera Therapeutics (KYMR) Bought Aug 20, 2024 · $46 · 1 shares Behind typical Sep 30, 2024 $47.33 → Mar 31, 2025 $27.37 · −42.2% (typical stock −7.5%)
Madrigal Pharmaceuticals (MDGL) Bought Dec 12, 2023 · $7.55M · 34,578 shares Beat typical Dec 31, 2023 $231.38 → Jun 30, 2024 $280.16 · +21.1% (typical stock −1.2%)

Each row is one stock in one quarter, however many buys it took. We take the stock's price at the end of that quarter and again 6 months later, and compare it with the typical stock over the same dates. Prices are quarter-end values from funds' 13F reports (the middle value across 3 or more funds), through Sep 30, 2026. Moves past 3 times up or down, mostly stock splits, are left out. How we tested this.

Past results. This is data, not advice.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist